203 related articles for article (PubMed ID: 8364205)
1. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases.
Desreumaux P; Janin A; Dubucquoi S; Copin MC; Torpier G; Capron A; Capron M; Prin L
Blood; 1993 Sep; 82(5):1553-60. PubMed ID: 8364205
[TBL] [Abstract][Full Text] [Related]
2. Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome.
Tajima K; Katagiri T
Dig Dis Sci; 1996 Feb; 41(2):282-8. PubMed ID: 8601370
[TBL] [Abstract][Full Text] [Related]
3. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease.
Tai PC; Ackerman SJ; Spry CJ; Dunnette S; Olsen EG; Gleich GJ
Lancet; 1987 Mar; 1(8534):643-7. PubMed ID: 2882081
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic myocarditis associated with dense deposits of eosinophil cationic protein (ECP) in endomyocardium with high serum ECP.
Arima M; Kanoh T
Heart; 1999 Jun; 81(6):669-71. PubMed ID: 10336931
[TBL] [Abstract][Full Text] [Related]
5. Eosinophilic myositis with eosinophilic cellulitislike skin lesions. Association with increased serum levels of eosinophil cationic protein and interleukin-5.
Trüeb RM; Lübbe J; Torricelli R; Panizzon RG; Wüthrich B; Burg G
Arch Dermatol; 1997 Feb; 133(2):203-6. PubMed ID: 9041834
[TBL] [Abstract][Full Text] [Related]
6. Eosinophilic major basic protein and interleukin-5 in eosinophilic myositis.
Murata K; Sugie K; Takamure M; Fujimoto T; Ueno S
Eur J Neurol; 2003 Jan; 10(1):35-8. PubMed ID: 12534990
[TBL] [Abstract][Full Text] [Related]
7. Electron-microscopic and immunohistochemical studies on endomyocardial biopsies from a patient with eosinophilic endomyocardial disease.
Nakayama Y; Kohriyama T; Yamamoto S; Deguchi H; Suwa M; Kino M; Hirota Y; Imamura K; Kitaura Y; Kawamura K
Heart Vessels Suppl; 1985; 1():250-5. PubMed ID: 3916475
[TBL] [Abstract][Full Text] [Related]
8. Eosinophils express a functional receptor for interferon alpha: inhibitory role of interferon alpha on the release of mediators.
Aldebert D; Lamkhioued B; Desaint C; Gounni AS; Goldman M; Capron A; Prin L; Capron M
Blood; 1996 Mar; 87(6):2354-60. PubMed ID: 8630398
[TBL] [Abstract][Full Text] [Related]
9. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma.
Niimi A; Amitani R; Suzuki K; Tanaka E; Murayama T; Kuze F
Clin Exp Allergy; 1998 Feb; 28(2):233-40. PubMed ID: 9515598
[TBL] [Abstract][Full Text] [Related]
10. The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils.
Tai PC; Spry CJ
Clin Exp Immunol; 1990 Jun; 80(3):426-34. PubMed ID: 2197048
[TBL] [Abstract][Full Text] [Related]
11. Tissue eosinophilia and eosinophil degranulation in orbital pseudotumor.
Noguchi H; Kephart GM; Campbell RJ; Li JT; Leiferman KM; Trocme SD; Gleich GJ
Ophthalmology; 1991 Jun; 98(6):928-32. PubMed ID: 1866147
[TBL] [Abstract][Full Text] [Related]
12. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease.
Talley NJ; Kephart GM; McGovern TW; Carpenter HA; Gleich GJ
Gastroenterology; 1992 Jul; 103(1):137-45. PubMed ID: 1612323
[TBL] [Abstract][Full Text] [Related]
13. [Changes in serum eosinophil cation protein level and blood eosinophil density in patients with asthma].
Wang H; Sun B
Zhonghua Nei Ke Za Zhi; 1995 Dec; 34(12):802-4. PubMed ID: 8731855
[TBL] [Abstract][Full Text] [Related]
14. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis.
Oh JW; Shin JC; Jang SJ; Lee HB
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):579-85. PubMed ID: 10400487
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.
Winqvist I; Olofsson T; Olsson I
Immunology; 1984 Jan; 51(1):1-8. PubMed ID: 6317543
[TBL] [Abstract][Full Text] [Related]
16. 1,1'-Ethylidenebis(tryptophan) (Peak E) induces functional activation of human eosinophils and interleukin 5 production from T lymphocytes: association of eosinophilia-myalgia syndrome with a L-tryptophan contaminant.
Yamaoka KA; Miyasaka N; Inuo G; Saito I; Kolb JP; Fujita K; Kashiwazaki S
J Clin Immunol; 1994 Jan; 14(1):50-60. PubMed ID: 8132737
[TBL] [Abstract][Full Text] [Related]
17. Wells' syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5.
España A; Sanz ML; Sola J; Gil P
Br J Dermatol; 1999 Jan; 140(1):127-30. PubMed ID: 10215782
[TBL] [Abstract][Full Text] [Related]
18. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival.
Meng Q; Ying S; Corrigan CJ; Wakelin M; Assoufi B; Moqbel R; Kay AB
Allergy; 1997 Nov; 52(11):1095-101. PubMed ID: 9404561
[TBL] [Abstract][Full Text] [Related]
19. Release of granule proteins from eosinophils cultured with IL-5.
Kita H; Weiler DA; Abu-Ghazaleh R; Sanderson CJ; Gleich GJ
J Immunol; 1992 Jul; 149(2):629-35. PubMed ID: 1624806
[TBL] [Abstract][Full Text] [Related]
20. The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer.
Trulson A; Nilsson S; Venge P
Br J Haematol; 1997 Aug; 98(2):312-4. PubMed ID: 9266926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
